Novartis profits drop 18% in Q1
This article was originally published in Scrip
Executive Summary
"Expected challenges" have hit pharma's former star performer Novartis as it reported an 18% drop in net income for the second quarter to $2.33 billion, while sales slipped 2% to $13.74 billion.